Alligator Bioscience Valuation Multiples

Alligator Bioscience Overview

About Alligator Bioscience

Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs focused on the CD40 receptor. Its drug candidate mitazalimab, is currently in preparation for Phase 3 development, and has previously presented unprecedented survival data at 18-months follow up in first-line metastatic pancreatic cancer patients in the Phase 2 trial OPTIMIZE-1.

Founded

2000

HQ

Employees

52

Website

alligatorbioscience.se

Sectors

BiopharmaceuticalsBioTech

Financials (LTM)

Revenue: —

EBITDA: ($10M)

EV

$20M

Valuation Multiples

Multiples.vc

Start free trial

Alligator Bioscience Financials

Alligator Bioscience reported last 12-month revenue of — and negative EBITDA of ($10M).

In the same LTM period, Alligator Bioscience generated — in gross profit, ($10M) in EBITDA losses, and had net loss of ($10M).

Alligator Bioscience P&L

In the most recent fiscal year, Alligator Bioscience reported revenue of $56K and EBITDA of ($558K).

Alligator Bioscience expects next 12-month revenue of XXX and NTM EBITDA of XXX

Alligator Bioscience Stock Performance

Alligator Bioscience has current market cap of $22M, and enterprise value of $20M.

Alligator Bioscience's stock price is $0.04.

Alligator Bioscience Valuation Multiples

Alligator Bioscience trades at 357.6x EV/Revenue multiple, and (2.0x) EV/EBITDA.

Alligator Bioscience Financial Valuation Multiples

As of April 21, 2026, Alligator Bioscience has market cap of $22M and EV of $20M.

Equity research analysts estimate Alligator Bioscience's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Alligator Bioscience has a P/E ratio of (2.2x).

Alligator Bioscience Margins & Growth Rates

Alligator Bioscience's revenue in the last fiscal year declined by (100%).

Alligator Bioscience's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.3M for the same period.

Alligator Bioscience Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Alligator Bioscience M&A Activity

Alligator Bioscience acquired XXX companies to date.

Last acquisition by Alligator Bioscience was on XXXXXXXX, XXXXX. Alligator Bioscience acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Alligator Bioscience Investment Activity

Alligator Bioscience invested in XXX companies to date.

Alligator Bioscience made its latest investment on XXXXXXXX, XXXXX. Alligator Bioscience invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).